Topical discussion will cover the latest issues and trends impacting credit quality in the U.S. health care sector including: continuing disruption, pharma pricing and potential federal legislation, emerging business models, and future perspective.
Prominent industry leaders will be joining senior S&P analysts to share their insights and perspectives.
Beth Ann Bovino, U.S. Chief Economist, S&P Global Ratings
Dr. Rod Hochman, Chief Executive Officer, Providence St. Joseph Health System
Anna Levchuk, Health Care Industry Head, S&P Global Market Intelligence
Gabe Petek, Legislative Analyst, California Legislative Analyst’s Office
Michael Neidorff, Chairman, President & CEO, Centene Corporation
Ron Rittenmeyer, Executive Chairman & CEO, Tenet Healthcare Corporation
Kyle Roland, Director – Investment Grade Health Care, Wells Fargo
Donato Tramuto, Chief Executive Officer, Tivity Health
Heather Wall, Chief Commercial Officer, Civica Rx
Click here to access the agenda.